BNET Industries
- Public
Dow Jones Description
In January 2006 the company was acquired by Teva Pharmaceutical Industries Ltd of Jerusalem, Israel.
President
Neil W. FlanzraichContact Information
Peer Companies
NAICS Code : 541710
Recent Events
-
Heavy hitters invest $31M in Opko
News & Analysis
Filter by
acquisition and ivax corp. - All News and Analysis
Research and Markets: In January 2006, Teva Completed Its Acquisition of IVAX, Further Strengthening Teva's Global Presence
- 2006-04-24
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c36063) has announced the addition of the Espicom Business Intelligence report "Teva Generics Company Intelligence Report" to their offering.
Research and Markets: The Largest Deal announced in the Third Quarter was the $7.4 billion Acquisition of Ivax by the Israel-based generics giant, Teva Pharmaceuticals
- 2006-03-31
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c32223) has announced the addition of Life Sciences Industry: Quarterly Deal Review -Third Quarter to their offering.
Research and Markets: Teva Pharmaceuticals Already has a UK Subsidiary but is Set to Increase its UK Presence via Its Acquisition of IVAX - Opportunities and Challenges in the UK Generic Pharmaceuticals Market 2006
- 2006-03-09
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c34159) has announced the addition of Espicom Business Intelligence's Opportunities and Challenges in the UK Generic Pharmaceuticals Market 2006 to their offering.
Teva Announces Final Results of Merger Consideration in Connection with Ivax Acquisition
- 2006-02-01
JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the final results of the elections made by the shareholders of Ivax Corporation for the form of merger consideration to be received in Teva's acquisition of Ivax, which closed on January 26, 2006.
Teva Completes Acquisition of IVAX; Strengthens Global Leadership in Generics, Adds New Product Lines and Growth Markets
- 2006-01-26
JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that it has completed its acquisition of IVAX Corporation (AMEX:IVX). The combined company, which will operate under the Teva name, will have a presence in over 60 countries and will employ approximately 26,000 people. The two companies generated over $7...
Teva and IVAX Receive European Commission Approval for Acquisition
- 2005-11-25
JERUSALEM & MIAMI -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) announced today that they received unconditional approval from the European Commission to proceed with Teva's acquisition of IVAX.
IVAX Receives Clearance Of Polish Anti-Monopoly Office For Acquisition Of Polfa Kutno; Polish Securities Commission Decision Expected Shortly
- 2004-05-21
Business Editors/Health/Medical Writers
IVAX Completes Acquisition of Nasarel and Nasalide Brand Products
- 2001-10-16
Business Editors/Health & Medical Writers
IVAX Enhances Its U.S. Respiratory Franchise With Acquisition of Two Intranasal Steroid Products From Elan Corporation
- 2001-09-26
Business Editors/Health & Medical Writers
IVAX Completes Acquisition of Leading Mexican Pharmaceutical Company
- 2001-02-13
Business Editors/Health & Medical Writers
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Neil W. Flanzraich | President |
| Jimmy Wang | CIO & Vice President |
| Nicholas Bodor | Chief Scientific Officer |
| Thomas E. Beier | CFO & Senior Vice President, Finance |
| Thomas E. McClary | Chief Accounting Officer |
| Rafick Henein | Senior Vice President |
| Steven D. Rubin | General Counsel, Senior Vice President & Secretary |
| Edmund Fry | Vice President, Compliance |
| J. Michael Lopez | Vice President, HR |
| Michael M. Lopez | Vice President, HR |
| Rao Uppaluri | Vice President, Strategic Planning |
| Roberto Prego | Vice President, Latin America |
| Stephen Sheriff | Vice President, Taxation & Tax Counsel |
| David Malina | Director, Investor Relations & Corp Communications |
| Hans Berner Soto | Director, Operations, Latin America |
| Bertram Pitt | |
| Betty G Amos | |
| David A. Lieberman | |
| Jack Fishman | |
| Mark Andrews | |
| Richard M Krasno |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | President | Current |
| Equity One, Inc. | Vice Chairman and President | Current |
| BELLUS Health Inc. | Consultant | Current |
| RAE Systems Inc. | Member, Chair | Current |
| Equity One, Inc. | Board of Directors | Current |
| Continucare Corporation | Director | Current |
| Chipotle Mexican Grill, Inc. | Director | Current |
| BELLUS Health Inc. | Director | Current |
| IVAX Corporation | Vice Chairman | Current |
| Harvard College | A.B | Former |
| Heller Ehrman LLP | Life Sciences Legal Practice Group Team | Former |
| Syntex Corporation | Former | |
| Israelamericafoundation.Com | Chairman | Former |
| RAE Systems Inc. | Board of Directors | Former |
| Harvard Law School | J.D. | Former |
| Harvard College | A.B. | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | CIO & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Chief Scientific Officer | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | CFO & Senior Vice President, Finance | Current |
| IVAX Diagnostics, Inc. | Cfo | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Chief Accounting Officer | Current |
| IVAX Diagnostics, Inc. | Vice President, Finance | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Senior Vice President | Current |
| Bioxelpharma Inc. | Board of Directors | Current |
| Ontario College of Pharmacists | Board of Directors | Current |
| Geopharma, Inc. | Director | Current |
| Dex-C20 | Director | Current |
| Ontario College of Pharmacists | Member | Current |
| IVAX Pharmaceuticals Inc. | President & CEO | Former |
| Novopharm Limited | Chief Operating Officer | Former |
| Novopharm Limited | Executive Vice President | Former |
| McGill University | Diploma In Management | Former |
| McGill University | MBA | Former |
| McGill University | Diploma In Management | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | General Counsel, Senior Vice President & Secretary | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Diagnostics, Inc. | Vice President, HR | Current |
| IVAX Corporation | Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, Strategic Planning | Current |
| IVAX Diagnostics, Inc. | Vice President, Strategic Planning | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Vice President, Latin America | Current |
| IVAX Diagnostics, Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Diagnostics, Inc. | Vice President | Current |
| IVAX Corporation | Vice President, Taxation & Tax Counsel | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Director, Investor Relations & Corp Communications | Current |
| IVAX Corporation | Director, Investor Relations & Corp Communications | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Director, Operations, Latin America | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Current | |
| Pharmaceutical Regulatory Services, Inc | Member of the Scientific Advisory Board | Current |
| University of Michigan | Professor of Internal Medicine | Former |
| Ephesus, Inc. | Co-Principal Investigator | Former |
| American Heart Association, Inc. | Chairman | Former |
| Medical School | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Current | |
| Bankatlantic Bancorp, Inc. | Board of Directors | Current |
| University of Miami | Senior Vice President for Business and Finance | Former |
| Foamex International Inc. | Director | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Current | |
| Weill Medical College of Cornell University | Chief Scientific Officer | Former |
| The Rockefeller University | Professor and Adjunct Professor | Former |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Current |
| Organization | Position | Status |
|---|---|---|
| IVAX Corporation | Current | |
| Pzk | Board of Directors | Current |
| Institute of International Education | Chief Executive Officer | Former |
| Institute of International Education | President | Former |
| Monterey Institute of International Studies | president | Former |
| Education, Inc. | Board of Directors | Former |
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
